Well, I guess, we will all have to sit back and wait to see just how NWBO will choose to write up the BLA in terms of what they try to get approval for and whether they use the new or old definitions of GBM, and how eventually the FDA chooses to respond should they approve, and what terminology they will use on their labels.
Market Data 
Markets 
AI
